Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia (Translation: The University of Toledo Journal of Medical Sciences, 2023)
Keywords: Multiple sclerosis; hypogammaglobulinemia; Infectious Diseases